amTCO, a new trans-cyclooctene derivative to study drug-target interactions in cells

Cécile Echalier1, Anna Rutkowska, Ana Kojic

  • 1European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. schultz@embl.de.

Chemical Communications (Cambridge, England)
|January 22, 2021
PubMed